AU2001294033A1 - Methods for treating disorders of the female reproductive system - Google Patents

Methods for treating disorders of the female reproductive system

Info

Publication number
AU2001294033A1
AU2001294033A1 AU2001294033A AU9403301A AU2001294033A1 AU 2001294033 A1 AU2001294033 A1 AU 2001294033A1 AU 2001294033 A AU2001294033 A AU 2001294033A AU 9403301 A AU9403301 A AU 9403301A AU 2001294033 A1 AU2001294033 A1 AU 2001294033A1
Authority
AU
Australia
Prior art keywords
methods
reproductive system
treating disorders
female reproductive
female
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001294033A
Inventor
Hilary Octavia Dawn Critchley
Rodney William Kelly
Anne Elizabeth King
Richard P. Phipps
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of AU2001294033A1 publication Critical patent/AU2001294033A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001294033A 2000-10-13 2001-10-15 Methods for treating disorders of the female reproductive system Abandoned AU2001294033A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0025132.2A GB0025132D0 (en) 2000-10-13 2000-10-13 Method
GB0025132.2 2000-10-13
PCT/GB2001/004566 WO2002030461A2 (en) 2000-10-13 2001-10-15 Methods for treating disorders of the female reproductive system

Publications (1)

Publication Number Publication Date
AU2001294033A1 true AU2001294033A1 (en) 2002-04-22

Family

ID=9901232

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001294033A Abandoned AU2001294033A1 (en) 2000-10-13 2001-10-15 Methods for treating disorders of the female reproductive system

Country Status (6)

Country Link
US (1) US20040052787A1 (en)
EP (1) EP1324772A2 (en)
JP (1) JP2004510828A (en)
AU (1) AU2001294033A1 (en)
GB (1) GB0025132D0 (en)
WO (1) WO2002030461A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2520026T3 (en) 2006-09-18 2014-11-11 The Board Of Trustees Of The University Of Arkansas Compositions and methods to boost immune responses
US20080305967A1 (en) * 2007-06-11 2008-12-11 Juneau Biosciences, Llc Genetic Markers Associated with Endometriosis and Use Thereof
US8932993B1 (en) 2007-06-11 2015-01-13 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor
US20080306034A1 (en) * 2007-06-11 2008-12-11 Juneau Biosciences, Llc Method of Administering a Therapeutic
WO2010124101A2 (en) * 2009-04-22 2010-10-28 Juneau Biosciences, Llc Genetic markers associated with endometriosis and use thereof
US9434991B2 (en) 2013-03-07 2016-09-06 Juneau Biosciences, LLC. Method of testing for endometriosis and treatment therefor

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1171374A (en) * 1981-04-13 1984-07-24 Takeda Chemical Industries, Ltd. Pseudo-aminosugars, their production and use
CA1202962A (en) * 1982-10-19 1986-04-08 David P. Clifford Substituted n-phenyl-n'-benzoyl ureas and their use as insecticides and acaricides
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4965188A (en) * 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US5961974A (en) * 1991-10-25 1999-10-05 Immunex Corporation Monoclonal antibodies to CD40 ligand, pharmaceutical composition comprising the same and hybridomas producing the same
AU680102B2 (en) * 1993-12-23 1997-07-17 Immunex Corporation Method of preventing or treating disease characterized by neoplastic cells expressing CD40
GB9425060D0 (en) * 1994-12-13 1995-02-08 Univ Birmingham Carcinoma treatment
US6340459B1 (en) * 1995-12-01 2002-01-22 The Trustees Of Columbia University In The City Of New York Therapeutic applications for the anti-T-BAM (CD40-L) monoclonal antibody 5C8 in the treatment of reperfusion injury in non-transplant recipients

Also Published As

Publication number Publication date
WO2002030461A2 (en) 2002-04-18
WO2002030461A3 (en) 2002-08-01
GB0025132D0 (en) 2000-11-29
EP1324772A2 (en) 2003-07-09
US20040052787A1 (en) 2004-03-18
JP2004510828A (en) 2004-04-08

Similar Documents

Publication Publication Date Title
AU2001285159A1 (en) Methods for treating endocrine disorders
AU2001238369A1 (en) Method for treating thyroid disorders
AU2001240115A1 (en) Method for the preparation of tetrahydrobenzothiepines
AU2001269799A1 (en) Methods for treating various eye disorders
WO2002030487A8 (en) Methods for treating aneurysms
AU2001240546A1 (en) Method for the preparation of hydrogenated hydrocarbons
AU2001288628A1 (en) Method and reagents for treatment of skin disorders by modulating the notch pathway
AU2001272928A1 (en) Distribution system
AU2001289194A1 (en) Method and system for facilitating the refinement of data queries
AU2001247893A1 (en) Method for facilitating commercial transactions
AU2001288271A1 (en) Methods for treating inflammatory diseases
AU2001294151A1 (en) System and method for the control of behavioral disorders
AU2002210385A1 (en) Furazanyl-triazole derivates for the treatment of diseases
AU2001237939A1 (en) Methods for treating glaucoma
AU2001230207A1 (en) Method for the production of 1-amino-3-aryl-uracils
AU3776799A (en) Methods for treating female sexual dysfunction
AU2002227895A1 (en) Sulphonamides for the treatment of central nervous system diseases
AU2002304931A1 (en) Methods for treating disorders of the nervous and reproductive systems
AU2001294033A1 (en) Methods for treating disorders of the female reproductive system
MXPA03004017A (en) Method for the treatment of inflammation.
AU2001280133A1 (en) Preventives and remedies for central nervous system diseases
AU2827100A (en) Process for the preparation of phenylhydrazines
AU2002258798A1 (en) Methods for the treatment of hepatic disorders
AU2001274518A1 (en) Account settling system
AU7451801A (en) Account settling system